Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) FCF Margin (2016 - 2025)

Orthofix Medical's FCF Margin history spans 16 years, with the latest figure at 7.65% for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 162.0% year-over-year to 7.65%, compared with a TTM value of 0.16% through Dec 2025, up 110.0%, and an annual FY2025 reading of 0.16%, up 106.0% over the prior year.
  • FCF Margin for Q4 2025 was 7.65% at Orthofix Medical, up from 1.21% in the prior quarter.
  • The five-year high for FCF Margin was 9.27% in Q4 2024, with the low at 28.04% in Q1 2023.
  • Average FCF Margin over 5 years is 4.75%, with a median of 4.71% recorded in 2022.
  • Year-over-year, FCF Margin tumbled -2703bps in 2021 and then surged 2077bps in 2024.
  • Tracing OFIX's FCF Margin over 5 years: stood at 7.92% in 2021, then crashed by -148bps to 3.81% in 2022, then plummeted by -202bps to 11.5% in 2023, then skyrocketed by 181bps to 9.27% in 2024, then decreased by -17bps to 7.65% in 2025.
  • Per Business Quant, the three most recent readings for OFIX's FCF Margin are 7.65% (Q4 2025), 1.21% (Q3 2025), and 2.37% (Q2 2025).